Tuesday, 3rd October
12th International Meeting on AMPK 2023
Days
Sunday, 1st October
Monday, 2nd October
Tuesday, 3rd October
Wednesday, 4th October
Thursday, 5th October
Search
Speakers
Registration Opens
8:30AM - 6:30PM
Tuesday, 3rd October
Convention Centre Foyer
2.1 Signalling by AMPK and Related Kinases I
9:00AM - 10:10AM
Tuesday, 3rd October
Convention Room 1 & 2
Chair: John Scott
Targeting CAMKK2 for the treatment of advanced prostate cancer
-
Daniel Frigo
CaMKK2: at the interface of nutrient sensing and cancer cell progression
-
Ayla Orang
Defining novel AMPK substrates by lysosome-enriched phosphoproteomics
-
Ashfaqul Hoque
Morning Tea
10:10AM - 11:00AM
Tuesday, 3rd October
Convention Room 1
2.2 Signalling by AMPK and Related Kinases II
11:00AM - 12:20PM
Tuesday, 3rd October
Convention Room 1 & 2
Chair: Janni Petersen
The role of AMPK in prostate cancer
-
David Carling
AMPK regulation of GBF1 controls Golgi morphology and trafficking
-
Jordana B Freemantle
Regulation of Pancreatic Beta-Cell Function by Salt-Inducible Kinases.
-
Kim Loh
Lunch
12:30PM - 2:00PM
Tuesday, 3rd October
Convention Room 1
2.3 AMPK in Neurobiology and Neuropathy I
2:00PM - 3:10PM
Tuesday, 3rd October
Convention Room 1 & 2
Chair: Sandrine Horman
“Cellular functions of the LKB1-NUAK1 signaling pathway during the development of the cerebral cortex”
-
Julien Courchet
Hypothalamic Salt-inducible kinase 3: A novel regulator of Energy Homeostasis
-
Danise Ann Onda
Serine threonine kinase 11 (liver kinase B1) SNP rs9282860 associates the diabetic peripheral neuropathy through the interaction of risk factors in Type 2 diabetic patients: Causal role of LKB1 and CREB binding sequence of SNP
-
Yasuo Ido
Afternoon Break
3:10PM - 4:00PM
Tuesday, 3rd October
Convention Room 1
2.4 AMPK in Muscle I
4:00PM - 5:20PM
Tuesday, 3rd October
Convention Room 1 & 2
Chairs: Mark Rider & Amanda Genders
AMPK as a mediator of tissue preservation: time for a shift in dogma?
-
Lykke Sylow
C18ORF25 is a novel exercise-regulated AMPK substrate regulating skeletal muscle function
-
Benjamin L Parker
Skeletal muscle signalling and metabolite networks underlying exercise and AMPK-glycogen interactions
-
Nolan J Hoffman
Posters Session #2
5:30PM - 6:30PM
Tuesday, 3rd October
Convention Room 1
Importance of liver-expressed SIK isoforms in the control of blood glucose levels
-
Marc Foretz
Abstract title: Characterisation of a novel AMPK inhibitor
-
Conchita Fraguas Bringas
Exploring the impact of AMPK signaling on the plasticity and differentiation of intestinal stem cells
-
Brittany Ellis Jewell
mTORC1 may inhibit AMPK a2b2g3 by phosphorylation of a2 ser345 and ser377 to suppress the insulin-sensitizing effect of exercise in humans
-
Magnus Romme Leandersson
Targeting AMPK activity to potentiate the action of venetoclax in leukemia
-
Juliet Mullen
Metformin induces an AMPK-independent
NEAT1
isoform switch in colorectal cancer cells
-
Nadine E Smith
Exploring the role of AMPK in bacterial infection
-
Tyler K.T. Smith
Low-dose metformin targets the lysosomal AMPK pathway through PEN2
-
Xiao Tian
The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
-
Yu Wang
Deciphering the role of AMPK in pancreatic cancer
-
Shira Yomtoubian
← Monday
Wednesday →